Acura Pharmaceuticals (Nasdaq: ACUR) announced that it has been awarded a $300,000 grant (the "Grant") by the National Institute On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE